Cargando…

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Detalles Bibliográficos
Autores principales:	Perna, Alessandra F., Capolongo, Giovanna, Trepiccione, Francesco, Simeoni, Mariadelina, Zacchia, Miriam, Ingrosso, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316655/ https://www.ncbi.nlm.nih.gov/pubmed/32450560 http://dx.doi.org/10.1159/000508460

Ejemplares similares

The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin
por: Perna, Alessandra F., et al.
Publicado: (2017)

Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium
por: Vigorito, Carmela, et al.
Publicado: (2019)

Zebrafish as a Model of Cardiac Pathology and Toxicity: Spotlight on Uremic Toxins
por: Coppola, Annapaola, et al.
Publicado: (2023)

ERK1,2 Signalling Pathway along the Nephron and Its Role in Acid-base and Electrolytes Balance
por: Capolongo, Giovanna, et al.
Publicado: (2019)

Zebrafish, a Novel Model System to Study Uremic Toxins: The Case for the Sulfur Amino Acid Lanthionine
por: Perna, Alessandra F., et al.
Publicado: (2018)

Therapeutic Plasmapheresis: A Revision of Literature
por: Altobelli, Claudia, et al.
Publicado: (2022)

The Gut Microbiota in Kidney Transplantation: A Target for Personalized Therapy?
por: García-Martínez, Yuselys, et al.
Publicado: (2023)

Secondary Hyperparathyroidism and Hypertension: An Intriguing Couple
por: Simeoni, Mariadelina, et al.
Publicado: (2020)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation
por: Zacchia, Miriam, et al.
Publicado: (2021)

Next-Generation Sequencing (NGS) Analysis Illustrates the Phenotypic Variability of Collagen Type IV Nephropathies
por: Zacchia, Miriam, et al.
Publicado: (2023)

The importance of the thick ascending limb of Henle’s loop in renal physiology and pathophysiology
por: Zacchia, Miriam, et al.
Publicado: (2018)

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
por: Lazrak, Hind Harrak, et al.
Publicado: (2017)

Bardet-Biedl Syndrome: Current Perspectives and Clinical Outlook
por: Melluso, Andrea, et al.
Publicado: (2023)

Uremic Toxin Lanthionine Induces Endothelial Cell Mineralization In Vitro
por: Coppola, Annapaola, et al.
Publicado: (2022)

Spontaneous Hemocholecyst in an End-Stage Renal Failure Patient on Low Molecular Weight Heparin Hemodialysis
por: Blouhos, Konstantinos, et al.
Publicado: (2012)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
por: Sottilotta, Gianluca, et al.
Publicado: (2021)

Multi-Omics Studies Unveil Extraciliary Functions of BBS10 and Show Metabolic Aberrations Underlying Renal Disease in Bardet–Biedl Syndrome
por: Marchese, Emanuela, et al.
Publicado: (2022)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Use of low-molecular-weight heparin in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

A point of view on hereditary thrombophilia and low-molecular-weight heparin incorporating the management in pregnancy and involving thyroidology
por: Dugalić, Stefan, et al.
Publicado: (2023)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19
por: Martinelli, Ida, et al.
Publicado: (2021)

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
por: Taleja, Hitesh, et al.
Publicado: (2021)

Efficacy and safety of low molecular weight heparin compared to unfractionated heparin for chronic outpatient hemodialysis in end stage renal disease: systematic review and meta-analysis
por: Palamaner Subash Shantha, Ghanshyam, et al.
Publicado: (2015)

Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study
por: Lazrak, Hind H., et al.
Publicado: (2018)

Effect of long‐term use of unfractionated or low‐molecular‐weight heparin on bone mineral density in maintenance hemodialysis patients
por: Yang, Shuo, et al.
Publicado: (2020)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

The Effect of Low Molecular Weight Heparins on Fracture Healing
por: Kapetanakis, Stylianos, et al.
Publicado: (2015)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

Management of intentional overdose of low-molecular-weight heparin
por: Lu, Clara, et al.
Publicado: (2022)

Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization
por: D’Ardes, Damiano, et al.
Publicado: (2020)

A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020)

Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme
por: Näsström, Birgit, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_0517up9nur7cfn2dcpc7borb9i